Elucidating the Role of Surfactant Protein D (SP-D) in Prostate Cancer
Not Applicable
- Conditions
- Health Condition 1: null- Suspected metastatic prostate cancer patients.
- Registration Number
- CTRI/2016/04/006890
- Lead Sponsor
- IRRH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 15
Inclusion Criteria
•Newly diagnosed patients with suspected metastatic prostate cancer [by clinical diagnosis and Ultrasound sonography (USG)]
•High PSA levels ( > 10ng/ml)
•Undergoing Prostate biopsy for their routine clinical care.
Exclusion Criteria
Prostate cancer patients undergoing
•Chemotherapy,
•Androgen deprivation therapy and
•Radiotherapy will be excluded.
•Therapy for any chronic ailment or infection
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method